Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626599 · ClinicalTrials.gov registry record · NA
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
A NA study, sponsored by Cyberonics.
- Completed
- Registry status
- NA
- Development phase
- 147
- Enrollment target
NCT01626599 is a NA study that has completed, run by Cyberonics. The registered enrollment target is 147 participants.
The verdict
NCT01626599, a NA study, has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
Study Summary
This study is designed to collect data to support development of a novel product designed to sense changes in heart rate or movement during periods of sleep in people with epilepsy. When a potential seizure is detected, the system sends out an audio-visual notification.
Interventions
- DEVICE ProGuardian
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626599
The ClinicalTrials.gov registry entry for NCT01626599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProGuardian is the first listed.
NCT01626599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01626599 about?
NCT01626599 is a clinical study titled "Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data". This study is designed to collect data to support development of a novel product designed to sense changes in heart rate or movement during periods of sleep in people with epilepsy. When a potential seizure is detected, the system sends out an audio-visual notification.
What is the current status of trial NCT01626599?
This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2012-06. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01626599?
The interventions under investigation include: ProGuardian (DEVICE).
Who is sponsoring clinical trial NCT01626599?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.